Received Nov 20, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | UNK | — | — |
previously had gotten her first 2 doses around 10 years ago; No symptomatic events reported; This spontaneous report was received from a medical assistant referring to a 36-year-old female patient. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On an unknown date in 2015 (around 10 years ago), the patient was vaccinated with her first two doses of Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL 9), Injection (strength, route, lot # and expiration date were not reported) for prophylaxis. The patient was looking to get her 3rd dose of Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL 9) (Inappropriate schedule of product administration). No adverse event was reported.